Literature DB >> 18798333

Mutation analysis of B3GALTL in Peters Plus syndrome.

Linda M Reis1, Rebecca C Tyler, Omar Abdul-Rahman, Pamela Trapane, Robert Wallerstein, Diane Broome, Jodi Hoffman, Aneal Khan, Christina Paradiso, Nitin Ron, Amanda Bergner, Elena V Semina.   

Abstract

Peters Plus syndrome comprises ocular anterior segment dysgenesis (most commonly Peters anomaly), short stature, hand anomalies, distinctive facial features, and often other additional defects and is inherited in an autosomal-recessive pattern. Mutations in the beta1,3-glucosyltransferase gene (B3GALTL) were recently reported in 20 out of 20 patients with Peters Plus syndrome. In our study, B3GALTL was examined in four patients with typical Peters Plus syndrome and four patients that demonstrated a phenotypic overlap with this condition. Mutations in B3GALTL were identified in all four patients with typical Peters Plus syndrome, while no mutations were found in the remaining four patients that demonstrated some but not all characteristic features of the syndrome. The previously reported common mutation, c.660 + 1G > A, accounted for 75% of the mutant alleles in our Peters Plus syndrome population. In addition, two new mutant alleles, c.459 + 1G > A and c.230insT, were identified and predicted to result in truncated protein products. These data confirm an important role for B3GALTL in causing typical Peters Plus syndrome, and suggest that this gene may not be implicated in syndromic cases that involve Peters anomaly but lack other classic features of this complex condition. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798333      PMCID: PMC2755183          DOI: 10.1002/ajmg.a.32498

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Peters' anomaly. The spectrum of associated ocular and systemic malformations.

Authors:  E Heon; M Barsoum-Homsy; L Cevrette; J L Jacob; J Milot; R Polemeno; M A Musarella
Journal:  Ophthalmic Paediatr Genet       Date:  1992-06

2.  Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain.

Authors:  Takashi Sato; Maiko Sato; Katsue Kiyohara; Maki Sogabe; Toshihide Shikanai; Norihiro Kikuchi; Akira Togayachi; Hiroyasu Ishida; Hiromi Ito; Akihiko Kameyama; Masanori Gotoh; Hisashi Narimatsu
Journal:  Glycobiology       Date:  2006-08-09       Impact factor: 4.313

Review 3.  Glycosylation in cellular mechanisms of health and disease.

Authors:  Kazuaki Ohtsubo; Jamey D Marth
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

4.  Murine ortholog of the novel glycosyltransferase, B3GTL: primary structure, characterization of the gene and transcripts, and expression in tissues.

Authors:  Taisto Y K Heinonen; Markku Pelto-Huikko; Leena Pasternack; Markku Mäki; Heikki Kainulainen
Journal:  DNA Cell Biol       Date:  2006-08       Impact factor: 3.311

5.  Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.

Authors:  Saskia A J Lesnik Oberstein; Marjolein Kriek; Stefan J White; Margot E Kalf; Karoly Szuhai; Johan T den Dunnen; Martijn H Breuning; Raoul C M Hennekam
Journal:  Am J Hum Genet       Date:  2006-07-19       Impact factor: 11.025

6.  Prenatal sonographic findings in Peters-plus syndrome.

Authors:  G Boog; C Le Vaillant; M Joubert
Journal:  Ultrasound Obstet Gynecol       Date:  2005-06       Impact factor: 7.299

7.  Kivlin syndrome and Peters'-Plus syndrome: are they the same disorder?

Authors:  E M Thompson; R M Winter; M Baraitser
Journal:  Clin Dysmorphol       Date:  1993-10       Impact factor: 0.816

Review 8.  Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause-Kivlin syndrome.

Authors:  M Frydman; A L Weinstock; H A Cohen; H Savir; I Varsano
Journal:  Am J Med Genet       Date:  1991-07-01

Review 9.  The Peters' plus syndrome: a review.

Authors:  Liesbeth J J M Maillette de Buy Wenniger-Prick; Raoul C M Hennekam
Journal:  Ann Genet       Date:  2002 Apr-Jun

10.  Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats.

Authors:  Daniel Hess; Jeremy J Keusch; Saskia A Lesnik Oberstein; Raoul C M Hennekam; Jan Hofsteenge
Journal:  J Biol Chem       Date:  2008-01-16       Impact factor: 5.157

View more
  25 in total

1.  Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.

Authors:  E Weh; L M Reis; R C Tyler; D Bick; W J Rhead; S Wallace; T L McGregor; S K Dills; M-C Chao; J C Murray; E V Semina
Journal:  Clin Genet       Date:  2013-09-17       Impact factor: 4.438

Review 2.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

3.  OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype.

Authors:  K F Schilter; A Schneider; T Bardakjian; J-F Soucy; R C Tyler; L M Reis; E V Semina
Journal:  Clin Genet       Date:  2011-02       Impact factor: 4.438

4.  Whole exome sequence analysis of Peters anomaly.

Authors:  Eric Weh; Linda M Reis; Hannah C Happ; Alex V Levin; Patricia G Wheeler; Karen L David; Erin Carney; Brad Angle; Natalie Hauser; Elena V Semina
Journal:  Hum Genet       Date:  2014-09-03       Impact factor: 4.132

5.  FOXE3 plays a significant role in autosomal recessive microphthalmia.

Authors:  Linda M Reis; Rebecca C Tyler; Adele Schneider; Tanya Bardakjian; Joan M Stoler; Serge B Melancon; Elena V Semina
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

6.  ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.

Authors:  Bernadette C Holdener; Christopher J Percival; Richard C Grady; Daniel C Cameron; Steven J Berardinelli; Ao Zhang; Sanjiv Neupane; Megumi Takeuchi; Javier C Jimenez-Vega; Sardar M Z Uddin; David E Komatsu; Robert Honkanen; Johanne Dubail; Suneel S Apte; Takashi Sato; Hisashi Narimatsu; Steve A McClain; Robert S Haltiwanger
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

Review 7.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

8.  Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia.

Authors:  Dominique Brémond-Gignac; Pierre Bitoun; Linda M Reis; Henri Copin; Jeffrey C Murray; Elena V Semina
Journal:  Mol Vis       Date:  2010-08-22       Impact factor: 2.367

9.  A 781-kb deletion of 13q12.3 in a patient with Peters plus syndrome.

Authors:  Chad R Haldeman-Englert; Taiyabah Naeem; Elizabeth A Geiger; Ashley Warnock; Holly Feret; Melissa Ciano; Stefanie L Davidson; Matthew A Deardorff; Elaine H Zackai; Tamim H Shaikh
Journal:  Am J Med Genet A       Date:  2009-08       Impact factor: 2.802

10.  6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2.

Authors:  Esam Al-Shareffi; Jean-Luc Chaubard; Christina Leonhard-Melief; Sheng-Kai Wang; Chi-Huey Wong; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2012-10-08       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.